The Latest Breaking News on Pharma

DC boss James Gunn shrugs off 'Shazam' star Zachary Levi's anti-Pfizer tweet

DC boss James Gunn has addressed a controversial tweet from Zachary Levi that called into question the "Shazam!" star's position on vaccines.

Los Angeles Times · Feb 1, 2023

GSK boss warns UK life sciences at ‘tipping point’ despite Sunak’s R&D pledge

Emma Walmsley says ambition to be pharma superpower at risk unless improvements made in key areas

The Guardian - UK · Feb 1, 2023

3 Biotech Stocks to Get in on Before It’s Too Late

Rapidly growing market for personalized medicines and revolutionary technologies like 3D bioprinting is expected to bolster the biotech industry. Moreover, rising government initiatives should support its growth. Hence, quality biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), and Jazz Pharmaceuticals (JAZZ) might be ideal buys. Continue reading.

StockNews.com · Feb 1, 2023

Prescription powers and Medicare rebate up for debate as premiers push for healthcare reform

State and territory leaders outline their wishlists before national cabinet meets on Friday

The Guardian - AU · Jan 31, 2023

Life science company which works on early cancer therapy and women's health takes space in MediCity Nottingham

New labs will allow team to carry out its own in-house testing, for more efficient and effective drug development

Birmingham Post · Jan 31, 2023

Some states may allow nurses to do more without doctors

When COVID-19 hit the United States in 2020, state policymakers across the country jumped to expand access to health care. They temporarily allowed more telehealth, for example, and made it easier for medical providers to practice across state lines.

Tribune News Service · Jan 31, 2023

Andhra Pradesh: 1 Killed As Reactor Explodes At Pharma Unit In Anakapalli

One person was killed after a reactor exploded at a pharma company in Anakapalli district of Andhra Pradesh on Wednesday. Read further on Dynamite News:

Dynamite News · Jan 31, 2023

AbbVie's blockbuster drug Humira finally loses its 20-year, $200 billion monopoly

U.S. doctors can now choose Amjevita instead, the first of several close copies of the popular rheumatoid arthritis drug expected this year. But industry-watchers warn consumer savings may be limited.

WEKU · Jan 31, 2023

Shanghai Composite Index Fell 0.42% on Tuesday

Shenzhen Component Index closed down 0.8%

Caixin Global · Jan 31, 2023

Urgent action needed to curb rise in prison deaths linked to spice, say UK researchers

Synthetic cannabinoids involved in nearly half of male prisoner deaths analysed in England and Wales

The Guardian - UK · Jan 31, 2023